mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.003 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.004 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.006 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |